Skip to main content
Fig. 1 | Cancer Cell International

Fig. 1

From: USP39 promotes malignant proliferation and angiogenesis of renal cell carcinoma by inhibiting VEGF-A165b alternative splicing via regulating SRSF1 and SRPK1

Fig. 1

The value of USP39 expression in renal cell carcinoma by ONCOMINE gene database analysis. A The expression of USP39 in renal clear cell carcinoma was significantly higher than that in normal renal tissue. B USP39 expression was associated with the malignant degree of kidney cancer. C Patients with high expression of USP39 had poor survival and prognosis. D The expression level of USP39 in patients who died at 5 years and those who survived. E, F The overall survival of patients with high or low expression of USP39 in different TNM stages. G, H Overall survival of patients with high or low expression of USP39 in different Fuhrman grades. CCRCC renal clear cell carcinoma, CRCC color renal cell carcinoma, PRCC papillary renal cell carcinoma. *P < 0.05; ***P < 0.001 versus normal renal tissue. *P < 0.05 versus deaths at 5 years

Back to article page